Metformin, a chemical relative of that compound, has been a top type 2 diabetes treatment in the United States since it was approved in 1994. It’s cheap—less than a dollar per dose—and readily ...

The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide from its ...

The pharmaceutical industry has seen a tremendous surge in the development of weight loss drugs, particularly GLP-1 receptor ...

Medicare coverage of weight loss drugs, if authorized, would increase federal spending by about $35B from 2026 to 2034, ...

The State Health Plan's decision to end coverage of certain weight-loss prescription drugs has produced an unlikely and ...

A surge of alternatives to newly popular weight-loss drugs is facing its biggest test yet after the FDA warned companies ...

Eli Lilly and Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the US, ...

Compounded versions of popular weight-loss drugs attracted telehealth companies that marketed services to connect patients ...

The Food and Drug Administration on Friday approved Regeneron Pharmaceuticals and Sanofi ... which includes medicines for cancer, obesity and another Sanofi-partnered drug, itepekimab, that’s in ...

WASHINGTON, 28th September, 2024 (WAM) -- The US Food and Drug Administration (FDA) has approved French pharmaceutical company Sanofi's Dupixent, an anti-bronchitis drug for smokers. According to the ...

A new drug has been approved for the treatment of schizophrenia in adults. On Thursday, the U.S. Food and Drug Administration (FDA) approved COBENFY (xanomeline and trospium chloride), an oral ...

People with schizophrenia will have a new treatment option for the first time in more than three decades, after the Food and Drug Administration Thursday approved a new kind of drug. Studies ...